Conclusions of the clinical study

An open-label study of herbal topical medication (psirelax) for patients with chronic plaque psoriasis. according to the rules of the Helsinki Committee.

Has been tested and proven in the framework of a clinical study according to the rules of the Helsinki Committee. The study was conducted by Dr. Yosef Shiri, Prof. Arnon Cohen and Dr. Assi Sikural, specialists in skin problems and reputable in clinical research and sponsored by "Meir" Hospital in Kfar Sava.

Conclusions: Effective, safe and without side effects.
Results:
73
% clinical success.

Psirelax (Psoriasis)

$ 41.39

It has been proven in medical clinical research according to the rules of the Helsinki Committee Has been tested and proven in the framewor...

Total: 0 $